Suchergebnisse

Lumentum Holdings LITE shares closed at $386.11 on Friday, which is close to the 52-week high of $401.60 it hit on Dec. 24, 2025. LITE shares have jumped a whopping 326.9% in a year, outperforming

OppFi Inc. OPFI shares have risen 36.3% over the past year. It has outpaced the 7.9% decline of its industry and 18.4% growth of the Zacks S&P 500 Composite.

1-Year Share Price Performance

Image

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to

Vertiv VRT shares have gained 31% in the trailing 12-month period, outperforming the broader Zacks Computer and Technology sector’s increase of 22.6%. The Zacks Computers - IT Services industry

Hennes & Mauritz AB (HNNMY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings

Investors might want to bet on Kezar Life Sciences, Inc. (KZR), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates

S&P Global (SPGI) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock

Investors might want to bet on Vivos Therapeutics, Inc. (VVOS), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces

MP Materials MP is trading at a forward 12-month price/sales multiple of 22.93X, a significant premium to the industry’s 1.44X. It has a Value Score of F, which suggests that the stock appears

Phillips 66 PSX is an integrated downstream player that refines crude oil into final products. It also transports and stores crude oil, natural gas, NGL and refined products through its pipeline

When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a

How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact your portfolio, but it can help you compare investment results across

How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact your portfolio, but it can help you compare investment results across

EMCOR Group, Inc. EME is entering a new phase of flexibility, powered by record operating cash flow and a fortress balance sheet. During the first nine months of 2025, it generated strong operating

It is never too late to invest in mutual funds for retirement. As such, if you plan to invest in some of the best funds, the Zacks Mutual Fund Rank can provide you with valuable guidance.

The